# Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia

> **NCT01516619** · PHASE2 · COMPLETED · sponsor: **Andres J. M. Ferreri** · enrollment: 3 (actual)

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Romiplostim

## Key facts

- **NCT ID:** NCT01516619
- **Lead sponsor:** Andres J. M. Ferreri
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516619, "Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01516619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*